Drug Trial Radar · NCT07279740
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Jun 2, 2026
Primary completion
Oct 1, 2027
Study completion Oct 1, 2027
Sponsor
- Lead sponsor
- Sunnybrook Health Sciences CentreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Alzheimer Society of Canada; Sunnybrook Research Institute; Brain Canada
- First posted
- Dec 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates whether the combined treatment of methylphenidate and non-invasive brain stimulation, called intermittent theta burst stimulation, can effectively treat apathy in individuals with Alzheimer's disease or mixed AD/vascular dementia
Conditions
- Alzheimer s Disease
- Alzheimer Dementia (AD)
- Alzheimer Dementia
- Alzheimer Disease
- Apathy
- Apathy in Dementia
Interventions
intermittent theta burst stimulation (iTBS)Device
iTBS is a form of repetitive transcranial magnetic simulation (rTMS), a non-invasive form of brain stimulation.
Methylphenidate (MPH)Drug
Participants will be on methylphenidate clinically prior to the trial
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Neuropsychiatric Inventory-Apathy (NPI-A) scoreTime frame: 2 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sunnybrook Research Institute
Toronto, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.